Advertisement

Topics

Companies Related to "A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)" [Most Relevant Company Matches] RSS

00:58 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)" found in our extensive corporate database of over 50,000 company records.

Showing "Study Evaluate Plasmin Creation Posterior Vitreous Detachment" Companies 1–25 of 1,100+

Relevant

Georgia Retina, P.C.

The physicians of Georgia Retina specialize in the diagnosis and treatment of diabetic retinopathy, macular pucker and macular holes, age-related macular degeneration, retinal detachment, proliferative vitreoretinopathy, ocular trauma, hereditary macular disease, retinopathy of prematurity and other forms of retinal and vitreous pathologies.


Vitreous-Retina-Macula Consultants of New York

Welcome to VRMNY.com, the web-site for Vitreous-Retina-Macula Consultants of New York, one of the premier single-specialty retina groups in the world. We are the largest retina practice in New York and one of the first to be established in the United States as a whole. The doctors of Vitreous-Retina-Macula Consultants of New York are leaders in the field who have been instrumental in the developme...

Evaluate, Ltd.

Evaluate is the trusted source for life science market intelligence and analysis with exclusive consensus forecasts to 2020. Evaluate supports life science and healthcare companies, financial institutions, consultancies and service providers in their strategic decision-making. Its services include EvaluatePharma, EvaluateClinicalTrials and EvaluateMedTe...


Molecular Innovations, Inc.

Molecular Innovations, Inc supplies researchers worldwide with high quality scientific and research products; including PAI-1, Renin, Prorenin, Vitronectin, Fibrinogen, Fibronectin, Plasminogen, Plasmin, Antithrombin, ELISA Kits, antibodies, and many other reagents for research use.

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Bright Pharmaceutical Services

Bright Pharmaceutical Services is a Contract Research Organization providing tailored services to clinical trials professionals. Experienced, stream-lined and efficient, you'll find Bright's approach to be a breath of fresh air. Bright staff members are committed to advancing medicine with the highest standards and ethics. Among our roster of services are:protocol development and design CRF cre...

VMR Institute

Welcome to VMR InstituteSince 1986 Jerry Sebag, MD has provided state-of-the-art care for disorders of the vitreous, macula, and retina. As a leading researcher, author, lecturer, and teacher, Dr. Sebag is able to offer patients pioneering treatments for blindness. As a co-investigator in various clinical research trials, Dr. Sebag offers patients new treatments and surgery not available at many o...

Vascular Dynamics, Inc.

Vascular Dynamics develops catheter-delivered technologies to bring a better quality of life to patients who are resistant to conventional treatments for hypertension. Vascular Dynamics was one of nine companies chosen in 2012 by the FDA to participate in the Early Feasibility Study IDE Pilot Program. The company is conducting open-label, controlled, multi...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

i3 Statprobe

Because we're strong in every area, you can outsource an entire study to i3 Statprobe, or outsource, for example, only the statistical programming for a single study. Or you can outsource only the statistical programming for every study. Use us any way you want to, we encourage it. For example, we'll provide a dedicated team of specialists (say, data coordinators or statistical programmers) to wor...

Evaluate Ltd.

Established in 1996, Evaluate Ltd. is the leader in high quality life science sector analysis. EvaluatePharma delivers exclusive consensus forecasts and trusted commercial insight into biotech and pharmaceutical performance. EvaluateMedTech sets a new standard in integrated analysis and consensus forecasts of the global medical device and diagnostic indust...

Probably Relevant

Protalex, Inc.

Protalex, Inc. is a clinical stage biopharmaceutical company that is developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including but not limited to, rheumatoid arthritis. Protalex’s lead product PRTX-100, which is formulated with a highly-purified form of staphylococcal protein A, has completed a Phase 1b...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

Refocus Group, Inc.

The Refocus Presbyopia Correction treatment is performed outside the optical zone on a binocular basis. The treatment utilizes an innovative Scleral Implant, along with specialized instrumentation including the Oculock and Scleratome for exact placement and precise creation of the scleral tunnels. Early data from the ongoing IDE FDA pivotal study presented...

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.

GlobalCare Clinical Trials, Ltd

GlobalCare Clinical Trials, Ltd, is the leading global provider of ambulant healthcare services for clinical trials to government agencies and the world’s biopharmaceutical and medical device companies engaged in all phases of product development. GlobalCare provides innovative, GCP-compliant services by conducting selected study visits in the home or...

PharmaLinkFHI, Inc.

PharmaLink provides complete eClinical research services to support and streamline the drug development process. Clinical teams leverage real-time study information to make immediate decisions based on emerging trends and study issues. Our accelerated processes, centralized information management and global reach make it possible to conduct trials of any size or complexity from virtually anywhere....

Providence Medical Technology

Providence Medical Technology is a private corporation focused on developing novel minimally invasive technologies. We are commercializing the DTRAX platform of posterior cervical devices, which are used to provide indirect decompression and fusion in patients suffering from cervical degenerative disease.

GlycoMark, Inc.

GlycoMark is an FDA-cleared blood test that reveals repeated episodes of postprandial hyperglycemia/glycemic variability by tracking postprandial glucose levels as they related to blood levels of the molecule 1,5-anhydroglucitol (1,5-AG). Multiple published studies indicate that 1,5-AG detects hyperglycemia not detected by the hemoglobin A1C test. A recent study conducted as part of the internat...

ACRO

Health outcomes aren't jeopardized when patients participate in randomized clinical trials of approved treatments, according to a new study. The results address misgivings some physicians have had about whether enrolling patients in a clinical trial might have a detrimental impact on their ability to receive individualized treatment. Conducted by a team led by Yale University's Dr. Cary P. Gross, ...

Sloan Valve Company

Sloan Valve Company is the world’s leading manufacturer of commercial plumbing systems and has been in operation since 1906. Headquartered in Franklin Park, Illinois, USA, the company is at the forefront of the green building movement and provides sustainable restroom solutions by manufacturing water-efficient products such as flush valves, electronic ...

Nanodisc, Inc.

Nanodisc, Inc. owns an exclusive, world-wide commercial license to all applications of Nanodiscs™ – nano scale, discoidal structures composed of specially engineered proteins and phospholipid bilayers. “Nanodiscs™ were discovered and developed by Dr. Sligar, Company Co-Founder, Professor at University of Illinois at Urbana Champaign and a principal investigator in the fede...

Longboat Clinical

Longboat is a clinical trials software company dedicated to generating better study outcomes by creating a complete support structure for site staff, patients, monitors, and study teams - where protocol compliance becomes easy and instinctive. In the complex world of clinical development, Longboat’s cloud-based site and patient engagement platform emp...

PRN Pharmaceutical Research Network

We provide consulting services to pharmaceutical research + development and marketing departments. We focus on clinical trial planning, feasibility of development plans, study design, protocol development, manuscript creation and management, lectures and physician education plans.We provide non-proprietary competitive intelligence and ophthalmic product feasibility assessments to financial and ph...

PharmaTech Solutions Inc

PTS was founded in 1999 by a group of pharmaceutical research professionals who believed that a pioneering approach was required to solve the industry’s study enrollment problems. Through innovation and excellence, PTS has amassed the technology and experience to develop patient recruitment solutions that identify and address the core issues that can hinder enrollment. PTS understands that findi...


More From BioPortfolio on "A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks